Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Antibody Mediated Rejection”

21 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 21 results

Not applicableUnknownNCT04414735
What this trial is testing

Impact of Photopheresis in the Prevention of Acute Rejection in Highly Sensitized de Novo Kidney Transplant Recipients

Who this might be right for
Kidney Transplant Rejection
Fundacion Clinic per a la Recerca Biomédica 30
Large-scale testing (Phase 3)Ended earlyNCT03994783
What this trial is testing

Transplant Antibody-Mediated Rejection: Guiding Effective Treatments

Who this might be right for
Kidney Transplant RejectionAntibody-mediated Rejection
Imperial College London 3
Testing effectiveness (Phase 2)Study completedNCT01147302
What this trial is testing

A Pilot Study to Evaluate the Use of C1 Esterase Inhibitor (Human) in Patients With Acute Antibody-Mediated Rejection

Who this might be right for
Graft Rejection
Shire 18
Testing effectiveness (Phase 2)Study completedNCT00771875
What this trial is testing

Randomized Trial for Mixed Acute Rejection

Who this might be right for
Graft Rejection
University of Cincinnati 30
Not applicableStudy completedNCT03393793
What this trial is testing

HEart trAnsplantation Registry of piTie-Salpetriere University Hospital

Who this might be right for
Cardiac Transplant DisorderCardiac DeathHeart Failure+5 more
Lee S Nguyen 566
Testing effectiveness (Phase 2)WithdrawnNCT02113891
What this trial is testing

Eculizumab Therapy for Subclinical Antibody-mediated Rejection in Kidney Transplantation

Who this might be right for
Subclinical Acute Antibody-mediated Rejection in Kidney Transplantation
Assistance Publique - Hôpitaux de Paris
Not applicableStudy completedNCT04367610
What this trial is testing

Effects of A Standardized Treatment Approach on Kidney Transplant Recipients With Antibody-Mediated Rejection

Who this might be right for
Antibody-mediated RejectionKidney Transplant RejectionGraft Loss
Istanbul University 75
Not applicableStudy completedNCT03719339
What this trial is testing

VIRTUUS Children's Study

Who this might be right for
Renal Transplant RejectionPediatric Kidney DiseaseEnd Stage Renal Disease+4 more
Children's Hospital of Philadelphia 445
Large-scale testing (Phase 3)Study completedNCT02013037
What this trial is testing

The De-novo Use of Eculizumab in Presensitized Patients Receiving Cardiac Transplantation

Who this might be right for
Antibody-mediated RejectionHyperacute Rejection of Cardiac TransplantLeft Ventricular Dysfunction+2 more
Cedars-Sinai Medical Center 36
Very early researchEnded earlyNCT03380936
What this trial is testing

Pilot Study of Treatment for Subclinical AMR (Antibody-mediated Rejection) in Kidney Transplant Recipients

Who this might be right for
Kidney Transplant Rejection
University of Colorado, Denver 4
Not applicableStudy completedNCT07700563
What this trial is testing

Development and Validation of HistoMX, a Gene-Expression Platform for Molecular Interpretation of Kidney Allograft Biopsies

Who this might be right for
Kidney TransplantRejection of Renal TransplantAntibody Mediated Rejection+4 more
Paris Translational Research Center for Organ Transplantation 2,410
Large-scale testing (Phase 3)Study completedNCT00275509
What this trial is testing

Induction Therapy Study in Live Donor Kidney Transplant Recipients With a Positive Crossmatch

Who this might be right for
Kidney Failure, Chronic
Johns Hopkins University 56
Large-scale testing (Phase 3)Ended earlyNCT02547220
What this trial is testing

Study to Evaluate the Efficacy and Safety of Cinryze® for the Treatment of Acute Antibody-mediated Rejection in Participants With Kidney Transplant

Who this might be right for
Acute Antibody-Mediated Rejection (AMR)
Shire 39
Large-scale testing (Phase 3)Enrolling By InvitationNCT06801886
What this trial is testing

Silymarin's Advantage on Graft Effectiveness

Who this might be right for
Posttransplant Diabetes MellitusAcute Graft RejectionBiopsy Proven Acute Rejection+2 more
University Hospital, Martin 130
Testing effectiveness (Phase 2)Ended earlyNCT01399593
What this trial is testing

Safety & Efficacy of Eculizumab to Prevent AMR in Living Donor Kidney Transplant Recipients Requiring Desensitization

Who this might be right for
Antibody Mediated Rejection
Alexion Pharmaceuticals, Inc. 102
Testing effectiveness (Phase 2)Study completedNCT04046549
What this trial is testing

Evaluate the Safety and Efficacy of Dual Costimulation Blockade With VIB4920 and Belatacept for Prophylaxis of Allograft Rejection in Adults Receiving a Kidney Transplant

Who this might be right for
AllograftsRejection; Transplant, KidneyTransplant Rejection+1 more
Amgen 25
Testing effectiveness (Phase 2)Study completedNCT02738918
What this trial is testing

Belatacept (Nulojix) in Renal Transplant Recipient With Mild Immunologic Risk Factor: a Pilot Prospective Study.

Who this might be right for
Renal TransplantAcute Antibody Mediated RejectionMild Immunologic Risk Factor
Assistance Publique - Hôpitaux de Paris 51
Not applicableLooking for participantsNCT07770659
What this trial is testing

Non-invasive Prediction of EArly Cardiac rEjection

Who this might be right for
Heart TransplantPediatric Heart TransplantRejection+2 more
Vanderbilt University Medical Center 200
Not applicableNot Yet RecruitingNCT04496037
What this trial is testing

Mechanistic Evaluation of Treatments for Acute Antibody-Mediated Rejection of the Kidney Transplant

Who this might be right for
Transplant; Complication, Rejection
Imperial College London 170
Not applicableLooking for participantsNCT07081126
What this trial is testing

Daratumumab for Late Antibody-Mediated Rejection

Who this might be right for
Kidney TansplantAcute Rejection (AR) of Transplanted Kidney
University Hospital, Martin 20
Next Page